Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Funder

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Hypertension (Dallas, Tex. : 1979)|July 23, 2019
Primary AldosteronismJohn W Funder
The Journal of Steroid Biochemistry and Molecular Biology|March 26, 2016
Genetic disorders in primary aldosteronism-familial and somaticJohn W Funder
Expert Opinion on Investigational Drugs|December 4, 2003
The role of mineralocorticoid receptor antagonists in the treatment of cardiac failureJohn W Funder
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Aldosterone resurgens--letter from EPHESUSJohn W Funder
Trends in Endocrinology and Metabolism: TEM|April 28, 2004
Is aldosterone bad for the heart?John W Funder
Progress in Cardiovascular Diseases|March 16, 2010
Aldosterone and mineralocorticoid receptors in the cardiovascular systemJohn W Funder
Endocrinology|April 23, 2009
The off-target effects of torcetrapibJohn W Funder
Hypertension (Dallas, Tex. : 1979)|November 1, 2006
Aldosterone and mineralocorticoid receptors: lessons from gene deletion studiesJohn W Funder
Future Cardiology|October 7, 2009
Eplerenone: hypertension, heart failure and the importance of mineralocorticoid receptor blockadeJohn W Funder
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 27, 2011
Eplerenone, amlodipine and experimental hypertension: one plus one equals threeJohn W Funder
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Hypertension (Dallas, Tex. : 1979)|July 23, 2019
Primary AldosteronismJohn W Funder
The Journal of Steroid Biochemistry and Molecular Biology|March 26, 2016
Genetic disorders in primary aldosteronism-familial and somaticJohn W Funder
Expert Opinion on Investigational Drugs|December 4, 2003
The role of mineralocorticoid receptor antagonists in the treatment of cardiac failureJohn W Funder
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Aldosterone resurgens--letter from EPHESUSJohn W Funder
Trends in Endocrinology and Metabolism: TEM|April 28, 2004
Is aldosterone bad for the heart?John W Funder
Progress in Cardiovascular Diseases|March 16, 2010
Aldosterone and mineralocorticoid receptors in the cardiovascular systemJohn W Funder
Endocrinology|April 23, 2009
The off-target effects of torcetrapibJohn W Funder
Hypertension (Dallas, Tex. : 1979)|November 1, 2006
Aldosterone and mineralocorticoid receptors: lessons from gene deletion studiesJohn W Funder
Future Cardiology|October 7, 2009
Eplerenone: hypertension, heart failure and the importance of mineralocorticoid receptor blockadeJohn W Funder
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 27, 2011
Eplerenone, amlodipine and experimental hypertension: one plus one equals threeJohn W Funder
Pageof 14